Why HealthEquity, Inc. (HQY) stock moved
HealthEquity, Inc. (HQY) shares rose 1.2% to $98.88 as of July 21, 2026, a modest gain from the prior close of $97.67. BestStocks flagged the session as a major change for HQY. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for HQY, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
HQY climbed 1.2% to $98.88
HealthEquity, Inc. (HQY) moved +3.81% from $95.07 to $98.69 on 2026-07-16, reaching a new 30-day high. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Monitor whether HQY sustains above $98.69 or pulls back; watch for upcoming earnings or analyst commentary that could validate the breakout.
What it means for HealthEquity, Inc. investors
For HealthEquity, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 1.2% session move; HealthEquity, Inc. (HQY) moved +3.81% from $95.07 to $98.69 on 2026-07-16, reaching a new 30-day high. Weighing against that: New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $107.43, implying +8.6% upside from $98.88. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 42 days out, the next report is the most likely near-term test of the move.
HQY price reaction
HQY last traded at $98.88, up $1.21 (+1.24%) from the previous close of $97.67. The session traded on 0.5× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $83.43 and $98.88, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on HealthEquity, Inc. (HQY)
The consensus analyst price target on HealthEquity, Inc. (HQY) is $107.43, 8.6% above the recent $98.88. Over the past 90 days analysts logged 0 upgrades, 4 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HQY line up.
The bullish case
- Wall Street's consensus price target of $107.43 implies +8.6% upside from $98.88.
- The Street's most bullish target is $111.00 (+12.3%).
- Positive 1.2% session move.
- HealthEquity, Inc. (HQY) moved +3.81% from $95.07 to $98.69 on 2026-07-16, reaching a new 30-day high.
- Positive price momentum.
The bearish case
- The bearish case is comparatively thin on recent signals; the main risk is that the climb toward the $107.43 consensus target has to be earned, and any of the risks BestStocks tracks could weigh on the shares.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for HQY
Frequently asked questions about HQY
Why did HealthEquity, Inc. (HQY) stock move?
HQY rose 1.2% to $98.88. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did HQY stock rise?
HQY gained 1.24% ($1.21) versus the prior close of $97.67, last trading at $98.88 on 0.5× average volume.
When is HealthEquity, Inc.'s next earnings date?
HQY's next earnings report is estimated for 2026-09-01 — about 42 days away.
What is the analyst price target for HQY?
The consensus analyst price target for HQY is $107.43, about 8.6% above the current $98.88. Over the past 90 days, analysts recorded 0 upgrades, 4 maintains, and 0 downgrades.
How BestStocks tracks HQY
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared HQY-specific materiality thresholds, triggering an evidence check. It draws on 8 tracked change events for HQY, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.